Synapsoft logo
AI Insights from Disclosures
Searching...
HANS BIOMED CORPORATION 042520
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
HANS BIOMED CORPORATION was established on September 15, 1999, for the purpose of researching, developing, manufacturing, and selling products such as skin and bone human tissue graft materials and medical devices. Its main products, human tissue graft materials for skin and bone such as Bella Cell HD and SureFuse, account for about 47% of revenue, while its medical device products such as Mint and hair transplant devices account for about 44% of revenue.
Representative Director Kim Geunyeong
Founded September 15, 1999
Corporation Type KOSDAQ
Industry Classification Manufacture of medical supplies and related other medicaments
Corporate number 11011-1773872
Business number 206-81-17637
Phone Number 02-466-2266
Fax Number 463-1554
Website hansbiomed.com
Company Address 7 Jeongui-ro 8-gil, Songpa-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant